ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages

  Simolin, Mikko A ^a   Pedersen, Tanja X ^b   Bro, Susanne ^b   Mäyränpää, Mikko I ^a   Helske, Satu ^a   Nielsen, Lars B ^b   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; APOLIPOPROTEIN E; CREATININE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA VALVE DISEASE; AORTA VALVE THICKENING; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENZYME INHIBITION; HISTOPATHOLOGY; HYPERLIPIDEMIA; KIDNEY DYSFUNCTION; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; UREMIA; ANIMAL; AORTA VALVE; AORTA VALVE STENOSIS; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; FIBROSIS; KIDNEY; KIDNEY FAILURE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; APOLIPOPROTEINS E; CREATININE; DISEASE MODELS, ANIMAL; ENALAPRIL; FIBROSIS; HYPERLIPIDEMIAS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRECTOMY; RENAL INSUFFICIENCY; RENIN-ANGIOTENSIN SYSTEM; UREA; UREMIA;

EID: 64049086254     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-10     Document Type: Article

References (44)

1. Foley RN Parfrey PS Sarnak MJ Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 1998, 32(5 Suppl 3):S112-9. 10.1053/ajkd.1998.v32.pm9820470 9820470
2. Maher ER Young G Smyth-Walsh B Pugh S Curtis JR Aortic and mitral valve calcification in patients with end-stage renal disease Lancet 1987, 2:875-877. 10.1016/S0140-6736(87)91370-5 2889080
3. Perkovic V Hunt D Griffin SV du Plessis M Becker GJ Accelerated progression of calcific aortic stenosis in dialysis patients Nephron Clin Pract 2003, 94:c40-5. 10.1159/000071280 12845236
4. Ohara T Hashimoto Y Matsumura A Suzuki M Isobe M Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis Circ J 2005, 69:1535-1539. 10.1253/circj.69.1535 16308504
5. Stewart BF Siscovick D Lind BK Gardin JM Gottdiener JS Smith VE Kitzman DW Otto CM Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study J Am Coll Cardiol 1997, 29:630-634. 10.1016/S0735-1097(96)00563-3 9060903
6. Lindroos M Kupari M Valvanne J Strandberg T Heikkila J Tilvis R Factors associated with calcific aortic valve degeneration in the elderly Eur Heart J 1994, 15:865-870. 7925504
7. Deutscher S Rockette HE Krishnaswami V Diabetes and hypercholesterolemia among patients with calcific aortic stenosis J Chronic Dis 1984, 37:407-415. 10.1016/0021-9681(84)90108-5 6715506
8. Otto CM Kuusisto J Reichenbach DD Gown AM O'Brien KD Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies Circulation 1994, 90:844-853. 7519131
9. Mohler ER 3rd Gannon F Reynolds C Zimmerman R Keane MG Kaplan FS Bone formation and inflammation in cardiac valves Circulation 2001, 103:1522-1528. 11257079
10. Helske S Syvaranta S Kupari M Lappalainen J Laine M Lommi J Turto H Mayranpaa M Werkkala K Kovanen PT Lindstedt KA Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves Eur Heart J 2006, 27:1495-1504. 10.1093/eurheartj/ehi706 16401677
11. Helske S Syvaranta S Lindstedt KA Lappalainen J Oorni K Mayranpaa MI Lommi J Turto H Werkkala K Kupari M Kovanen PT Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves Arterioscler Thromb Vasc Biol 2006, 26:1791-1798. 10.1161/01.ATV.0000228824.01604.63 16728655
12. O'Brien KD Shavelle DM Caulfield MT McDonald TO Olin-Lewis K Otto CM Probstfield JL Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 2002, 106:2224-2230. 10.1161/01.CIR.0000035655.45453.D2 12390952
13. Helske S Lindstedt KA Laine M Mayranpaa M Werkkala K Lommi J Turto H Kupari M Kovanen PT Induction of local angiotensin II-producing systems in stenotic aortic valves J Am Coll Cardiol 2004, 44:1859-1866. 10.1016/ j.jacc.2004.07.054 15519020
14. Kwon HM Lee BK Kim D Hong BK Byun KH Kna JS Kim IJ Oh SH Kim HS Experimental hypercholesterolemia induces ultrastructural changes in the elastic laminae of rabbit aortic valve Yonsei Med J 1998, 39:345-354. 9752801
15. Rajamannan NM Subramaniam M Springett M Sebo TC Niekrasz M McConnell JP Singh RJ Stone NJ Bonow RO Spelsberg TC Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve Circulation 2002, 105:2660-2665. 10.1161/01.CIR.0000017435.87463.72 12045173
16. Drolet MC Arsenault M Couet J Experimental aortic valve stenosis in rabbits J Am Coll Cardiol 2003, 41:1211-1217. 10.1016/ S0735-1097(03)00090-1 12679224
17. Arishiro K Hoshiga M Negoro N Jin D Takai S Miyazaki M Ishihara T Hanafusa T Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits J Am Coll Cardiol 2007, 49:1482-1489. 10.1016/j.jacc.2006.11.043 17397679
18. Tanaka K Sata M Fukuda D Suematsu Y Motomura N Takamoto S Hirata Y Nagai R Age-associated aortic stenosis in apolipoprotein E-deficient mice J Am Coll Cardiol 2005, 46:134-141. 10.1016/j.jacc.2005.03.058 15992647
19. Weiss RM Ohashi M Miller JD Young SG Heistad DD Calcific aortic valve stenosis in old hypercholesterolemic mice Circulation 2006, 114:2065-2069. 10.1161/CIRCULATIONAHA.106.634139 17075015
20. Drolet MC Roussel E Deshaies Y Couet J Arsenault M A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice J Am Coll Cardiol 2006, 47:850-855. 10.1016/j.jacc.2005.09.049 16487855
21. Bro S Bentzon JF Falk E Andersen CB Olgaard K Nielsen LB Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice J Am Soc Nephrol 2003, 14:2466-2474. 10.1097/01.ASN.0000088024.72216.2E 14514724
22. Bro S Binder CJ Witztum JL Olgaard K Nielsen LB Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 2007, 27:1080-1086. 10.1161/ATVBAHA.107.139634 17347482
23. Routledge HC Townend JN ACE inhibition in aortic stenosis: Dangerous medicine or golden opportunity? J Hum Hypertens 2001, 15:659-667. 10.1038/sj.jhh.1001260 11607794
24. Mehta PK Griendling KK Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 2007, 292:C82-97. 10.1152/ajpcell.00287.2006 16870827
25. O'Brien KD Zhao XQ Shavelle DM Caulfield MT Letterer RA Kapadia SR Probstfield JL Otto CM Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function J Investig Med 2004, 52:185-191. 10.2310/6650.2004.03025 15222408
26. Chockalingam A Venkatesan S Subramaniam T Jagannathan V Elangovan S Alagesan R Gnanavelu G Dorairajan S Krishna BP Chockalingam V Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS) Am Heart J 2004, 147:E19. 10.1016/j.ahj.2003.10.017 15077102
27. Jimenez-Candil J Bermejo J Yotti R Cortina C Moreno M Cantalapiedra JL Garcia-Fernandez MA Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: A drug withdrawal study Heart 2005, 91:1311-1318. 1769141 16162624 10.1136/hrt.2004.047233
28. O'Brien KD Probstfield JL Caulfield MT Nasir K Takasu J Shavelle DM Wu AH Zhao XQ Budoff MJ Angiotensin-converting enzyme inhibitors and change in aortic valve calcium Arch Intern Med 2005, 165:858-862. 10.1001/ archinte.165.8.858 15851635
29. Rosenhek R Rader F Loho N Gabriel H Heger M Klaar U Schemper M Binder T Maurer G Baumgartner H Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 2004, 110:1291-1295. 10.1161/01.CIR.0000140723.15274.53 15337704
30. Maher ER Pazianas M Curtis JR Calcific aortic stenosis: A complication of chronic uraemia Nephron 1987, 47:119-122. 10.1159/000184472 3696315
31. Baglin A Hanslik T Vaillant JN Boulard JC Moulonguet-Doleris L Prinseau J Severe valvular heart disease in patients on chronic dialysis. A five-year multicenter French survey Ann Med Interne (Paris) 1997, 148:521-526. 9538397
32. Raine AE Acquired aortic stenosis in dialysis patients Nephron 1994, 68:159-168. 10.1159/000188251 7830852
33. Urena P Malergue MC Goldfarb B Prieur P Guedon-Rapoud C Petrover M Evolutive aortic stenosis in hemodialysis patients: Analysis of risk factors Nephrologie 1999, 20:217-225. 10480155
34. London GM Pannier B Marchais SJ Guerin AP Calcification of the aortic valve in the dialyzed patient J Am Soc Nephrol 2000, 11:778-783. 10752538
35. Vlahakos DV Hahalis G Vassilakos P Marathias KP Geroulanos S Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients J Am Soc Nephrol 1997, 8:1764-1770. 9355080
36. Pedersen TF Nielsen AH Strandgaard S Paulson OB Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat J Renin Angiotensin Aldosterone Syst 2002, 3:130-134. 10.3317/ jraas.2002.015 12228855
37. Campbell DJ Circulating and tissue angiotensin systems J Clin Invest 1987, 79:1-6. 423969 3025255 10.1172/JCI112768
38. Rajamannan NM Subramaniam M Caira F Stock SR Spelsberg TC Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway Circulation 2005, 112(9 Suppl):I229-34. 16159822
39. Rajamannan NM Subramaniam M Stock SR Stone NJ Springett M Ignatiev KI McConnell JP Singh RJ Bonow RO Spelsberg TC Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve Heart 2005, 91:806-810. 1768932 15894785 10.1136/hrt.2003.029785
40. Nandeesha H Pavithran P Madanmohan T Effect of Antihypertensive Therapy on Serum Lipids in Newly Diagnosed Essential Hypertensive Men Angiology 2008.
41. Rossebo AB Pedersen TR Boman K Brudi P Chambers JB Egstrup K Gerdts E Gohlke-Barwolf C Holme I Kesaniemi YA Malbecq W Nienaber CA Ray S Skjaerpe T Wachtell K Willenheimer R SEAS Investigators Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 2008, 359:1343-1356. 10.1056/NEJMoa0804602 18765433
42. Otto CM Burwash IG Legget ME Munt BI Fujioka M Healy NL Kraft CD Miyake-Hull CY Schwaegler RG Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome Circulation 1997, 95:2262-2270. 9142003
43. Otto CM Lind BK Kitzman DW Gersh BJ Siscovick DS Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 1999, 341:142-147. 10.1056/NEJM199907153410302 10403851
44. Westenfeld R Schafer C Smeets R Brandenburg VM Floege J Ketteler M Jahnen-Dechent W Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice Nephrol Dial Transplant 2007, 22:1537-1546. 10.1093/ndt/gfm094 17389622